$9.980
0.000 (0.00%)收盘时
- 最高
- 9.980
- 开盘
- 9.980
- 成交量加权均价
- 9.98
- 成交量
- 20.00
- 市值
- —
- 最低
- 9.980
- 成交额
- 199.60
- 企业价值/息税折旧摊销前利润(TTM)
- 0.00
Rainier Acquisition Corporation is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The Company has not selected any business combination, has conducted no operations and has generated no revenues. It intends to focus on life sciences companies that apply biology to improve human health.
AI 分析 of Rainier Acquisition Corporation Class A Ordinary Shares (RNAQ)
卖出Rainier Acquisition Corp (RNAQ) is not a good buy right now due to its low current ratio of 0.18, indicating potential liquidity issues, and a negative total equity of -7293.00 USD, which raises concerns about its financial health. Additionally, the stock is trading at a 52-week low of 9.90, which is only 13.3% of its 52-week range, suggesting it is underperforming. The RSI is at 38.423, indicating it is nearing oversold conditions but lacks a strong buy signal. The main risk is its total debt of 25000.00 USD against its low current assets of 17707.00 USD, which could lead to financial instability.
估值指标
事件时间线
RNAQ 常见问题 —— 由 Alphio AI 解答
Rainier Acquisition Corporation is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The Company has not selected any business combination, has conducted no operations and has generated no revenues. It intends to focus on life sciences companies that apply biology to improve human health.
Rainier Acquisition Corp (RNAQ) is not a good buy right now due to its low current ratio of 0.18, indicating potential liquidity issues, and a negative total equity of -7293.00 USD, which raises concerns about its financial health. Additionally, the stock is trading at a 52-week low of 9.90, which is only 13.3% of its 52-week range, suggesting it is underperforming. The RSI is at 38.423, indicating it is nearing oversold conditions but lacks a strong buy signal. The main risk is its total debt of 25000.00 USD against its low current assets of 17707.00 USD, which could lead to financial instability.
社区
更多 ↗暂无帖子
注册或登录后参与讨论相关文章
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。